Neostigmine Methylsulfate Injection
Product Images NDC 71288-501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 71288-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Neo0h 0001 01)

FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Carton (Neostig 10mg Carton)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Carton (Neostig 10mg Carton)
Neostigmine Methylsulfate Injection, USP is a medication used for intravenous use. It is provided in 10x10 mL multi-dose vials containing 1mg per mL of Neostigmine Methylsulfate. Each mL also contains Phencl 4.5 mg and Sodium Acetat Hyate 0.2 mg. The pH is adjusted with Gacl actc acd and io sodium hyoide as necessary. The medication should be stored at 25°C and protected from light. The container dosur is not made with natural rubber latex. The package is sterile and nonpyrogenic. Additional information, including dosage and directions for use, are not available.*
FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Vial Label (Neostig 10mg Vial)

FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Carton (Neostig 5mg Carton)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Carton (Neostig 5mg Carton)
This is a description of a medication called Methylsulfate Injection, USP. It comes in a multi-dose vial with a capacity of 10 mL or 1010 mL and is intended for intravenous use. The primary components of the medication include Neostignine Methylufte, Phenc, and Actatehyiate. The container dosure is not made with natural rubber latex. The medication should be stored between 20°10 and 25° C, with excursions permitted between 15°10 and 0° or 59°10 and 86° F. The medication requires protection from light and should be stored in the crate until use. Additionally, directions for use are included in the package insert. The text has some errors.*
FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Vial Label (Neostig 5mg Vial)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Vial Label (Neostig 5mg Vial)
This is a description of a medication called BOIE4AUSOT-00, which is manufactured by Meitheal Pharmaceuticals. The medication is described as sterile and nonpyrogenic, with a composition that includes 0.5 mg of Methylsulfate per mL for intravenous use. It comes in a 10 mL Multi-Dose vial injection with a concentration of 5mg per 10. The medication has a National Drug Code (NDC) number of 71288-500-10 and is only available by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.